• Enhanced CAR T cell therapy offers new strategy for lymphoma May 07, 2025 A phase I study of a next-generation CAR T cell therapy showed a 52 percent complete remission rate for patients with relapsed/refractory lymphoma.
• Deeply Rooted models community-academic action for health justice May 05, 2025 Deeply Rooted has planted over 1,000 trees, greened over 1,000 vacant lots, and funded 79 community grants.
• New AI technique uncovers antiviral compounds April 29, 2025 New Penn Medicine research finds that AI algorithms, when combined with traditional laboratory methods, can uncover promising drug leads against human enterovirus 71.
• Penn Medicine breaks ground on fourth proton therapy center April 28, 2025 Penn Medicine celebrated the groundbreaking of the Roberts Proton Therapy Center at Penn Presbyterian Medical Center in University City, which is expected to open for patient care in late 2027.
• New Medicare program could cut drug cost–if patients enroll April 28, 2025 Analysis finds the Medicare Prescription Payment Plan (MPPP) could help patients avoid large out-of-pocket payments for their first oral cancer prescription.

Use arrow keys to view news

Use arrow keys to view events